RVVTF - Revive Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

12.07M

Cash

2.655M

Avg Qtr Burn

-1.749M

Short % of Float

0.00%

Insider Ownership

2.49%

Institutional Own.

2.63%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Bucillamine Details COVID-19	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.